Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guan Xin Dan Shen Jiao Nang (also known as Guanxin Danshen Capsules) is an approved traditional Chinese medicine (TCM) formulation developed and manufactured by Sinopharm Group Zhijun. It is formulated as an oral capsule containing a mixture of three active botanical ingredients: Salvia miltiorrhiza (Danshen), Panax notoginseng (Sanqi), and Dalbergia odorifera oil (Jiangxiang oil). The formulation is indicated for the treatment of chest tightness, chest pain, coronary artery disease, and angina pectoris caused by qi stagnation and blood stasis. Mechanistically, it promotes blood circulation, resolves blood stasis, regulates qi, and relieves pain by improving microcirculation, increasing coronary blood flow, and inhibiting platelet aggregation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Guan Xin Dan Shen Jiao Nang.